Skip to content

Hexarelin studies: 245 papers with results

Page 4 of 5

  1. Growth hormone responses to growth hormone-releasing hormone and hexarelin in fed and fasted dogs: effect of somatostatin infusion or pretreatment with pirenzepine.

    Rigamonti AE · The Journal of endocrinology · 1998

    Animal study (in vivo) · dog · 7 results

  2. Effect of long-term administration of Hexarelin on the somatotrophic axis in aged rats.

    Cattaneo L · Pharmacological research · 1997

    Animal study (in vivo) · rat · 8 results

  3. Hexarelin stimulation of growth hormone release and mRNA levels in an infant and adult rat model of impaired GHRH function.

    Torsello A · Neuroendocrinology · 1997

    Animal study (in vivo) · rat · 7 results

  4. Feeding behavior during long-term hexarelin administration in young and old rats.

    Bresciani E · Journal of endocrinological investigation · 2008

    Animal study (in vivo) · rat · 6 results

  5. Hexarelin attenuates abdominal aortic aneurysm formation by inhibiting SMC phenotype switch and inflammasome activation.

    Jiang B · Microvascular research · 2022

    Animal study (in vivo) · mouse · 8 results

  6. Improvement of cardiomyocyte function by in vivo hexarelin treatment in streptozotocin-induced diabetic rats.

    Zhang X · Physiological reports · 2018

    Animal study (in vivo) · rat · 7 results

  7. Growth hormone attenuates branchial HSP70 expression in silver sea bream.

    Deane EE · Fish physiology and biochemistry · 2010

    Animal study (in vivo) · silver sea bream · 2 results

  8. Bone effects of hexarelin, a GH-releasing peptide, in female rats: influence of estrogen milieu.

    Sibilia V · European journal of endocrinology · 2002

    Animal study (in vivo) · rat · 11 results

  9. Hexarelin, but not growth hormone, protects heart from damage induced in vitro by calcium deprivation replenishment.

    Torsello A · Endocrine · 2001

    Animal study (in vivo) · rat · 5 results

  10. Enhanced Pulsatile Growth Hormone Secretion and Altered Metabolic Hormones by in Vivo Hexarelin Treatment in Streptozotocin-Induced Diabetic Rats.

    Zhang X · International journal of molecular sciences · 2018

    Animal study (in vivo) · rat · 5 results

  11. Radioimmunoassay for hexarelin, a peptidic growth hormone secretagogue, and its pharmacokinetic studies.

    Roumi M · Peptides · 1995

    Animal study (in vivo) · dog · 9 results

  12. Using Synchrotron Radiation Imaging Techniques to Elucidate the Actions of Hexarelin in the Heart of Small Animal Models.

    Waddingham MT · Frontiers in physiology · 2021

    Animal study (in vivo) · rat · 4 results

  13. The influence of sex and gonadectomy on the growth hormone and corticosterone response to hexarelin in the rat.

    Sibilia V · Life sciences · 2000

    Animal study (in vivo) · rat · 4 results

  14. Growth Hormone (GH) but not IGF-I-Secretion is Stimulated in Aged Rats by Chronic Hexarelin and GHRP-6 administration.

    Settembrini B · Endocrine regulations · 1998

    Animal study (in vivo) · rat · 15 results

  15. Histopathological and immunohistochemical characterization of MPTP-associated pancreatic injury and its attenuation by Hexarelin in mice.

    Şahin M · Journal of molecular histology · 2026

    Animal study (in vivo) · mouse · 6 results

  16. Protective and restorative effects of hexarelin on MPTP-induced lung injury in mice.

    Celikoglu O · Journal of basic and clinical physiology and pharmacology · 2026

    Animal study (in vivo) · mouse · 5 results

  17. Hexarelin promotes the survival of retinal ganglion cells after optic nerve transection.

    Chow KBS · Indian journal of pharmacology · 2026

    Animal study (in vivo) · golden hamster · 6 results

  18. The effects of a continuous infusion of hexarelin on pulsatile growth hormone release, growth axis and galanin gene expression and on the response of the growth axis to growth hormone-releasing hormone.

    Conley LK · Pituitary · 2000

    Animal study (in vivo) · rat · 8 results

  19. Growth hormone secretagogue binding sites in peripheral human tissues.

    Papotti M · The Journal of clinical endocrinology and metabolism · 2000

    Ex vivo tissue · 7 results

  20. Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines.

    Cassoni P · The Journal of clinical endocrinology and metabolism · 2001

    Ex vivo tissue · 4 results

  21. Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor.

    Muccioli G · European journal of pharmacology · 2004

    Ex vivo tissue · rat · 6 results

  22. Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln14-ghrelin.

    Bedendi I · European journal of pharmacology · 2003

    Ex vivo tissue · guinea pig · 3 results

  23. CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart.

    Bodart V · Circulation research · 2002

    Ex vivo tissue · mouse and rat · 5 results

  24. Binding of 125I-labeled ghrelin to membranes from human hypothalamus and pituitary gland.

    Muccioli G · Journal of endocrinological investigation · 2001

    Ex vivo tissue · 2 results

  25. Identification and characterization of a new growth hormone-releasing peptide receptor in the heart.

    Bodart V · Circulation research · 1999

    Ex vivo tissue · rat · 11 results

  26. Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart.

    Frascarelli S · Basic research in cardiology · 2003

    Ex vivo tissue · rat · 5 results

  27. The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants.

    Korbonits M · Journal of neuroendocrinology · 1999

    Ex vivo tissue · rat · 11 results

  28. Growth hormone secretagogues protect mouse cardiomyocytes from in vitro ischemia/reperfusion injury through regulation of intracellular calcium.

    Ma Y · PloS one · 2012

    Ex vivo tissue · mouse · 5 results

  29. Effects of GH secretagogues on contractility and Ca2+ homeostasis of isolated adult rat ventricular myocytes.

    Sun Q · Endocrinology · 2010

    Ex vivo tissue · rat · 7 results

  30. Doping control analysis of seven bioactive peptides in horse plasma by liquid chromatography-mass spectrometry.

    Kwok WH · Analytical and bioanalytical chemistry · 2013

    Ex vivo tissue · horse · 12 results

  31. Growth hormone secretagogues preserve the electrophysiological properties of mouse cardiomyocytes isolated from in vitro ischemia/reperfusion heart.

    Ma Y · Endocrinology · 2012

    Ex vivo tissue · mouse · 9 results

  32. FAT/CD36 regulates PEPCK expression in adipose tissue.

    Wan Z · American journal of physiology. Cell physiology · 2013

    Ex vivo tissue · mouse · 1 result

  33. Somatostatin octapeptides (lanreotide, octreotide, vapreotide, and their analogs) share the growth hormone-releasing peptide receptor in the human pituitary gland.

    Deghenghi R · Endocrine · 2001

    Ex vivo tissue · 4 results

  34. Growth hormone secretagogues reduce transient outward K+ current via phospholipase C/protein kinase C signaling pathway in rat ventricular myocytes.

    Sun Q · Endocrinology · 2010

    Ex vivo tissue · rat · 5 results

  35. Growth hormone secretagogue (GHS) analogue, hexarelin stimulates GH from peripheral lymphocytes.

    Poppi L · Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association · 2002

    Ex vivo tissue · cattle and pig · 4 results

  36. Role of endothelial cells in modulation of contractility induced by hexarelin in rat ventricle.

    Bedendi I · Life sciences · 2001

    Ex vivo tissue · rat · 14 results

  37. Permeability of the peptidic GH secretagogues hexarelin and EP 51389, across rat jejunum.

    Roumi M · Peptides · 2001

    Ex vivo tissue · rat · 4 results

  38. Growth hormone secretagogues exert differential effects on skeletal muscle calcium homeostasis in male rats depending on the peptidyl/nonpeptidyl structure.

    Liantonio A · Endocrinology · 2013

    Ex vivo tissue · rat · 1 result

  39. Hexarelin--evaluation of factors influencing oral bioavailability and ways to improve absorption.

    Westberg C · The Journal of pharmacy and pharmacology · 2001

    Ex vivo tissue · 7 results

  40. Hepatic extraction of hexarelin, a new peptidic GH secretagogue, in the isolated perfused rat liver.

    Roumi M · Pharmaceutical research · 1997

    Ex vivo tissue · rat and dog · 10 results

  41. Interaction of the novel GH secretagogue hexarelin with GHRH in regulating the secretion of GH by cultured human pituitary somatotrophinomas in vitro.

    Liu Q · Journal of Tongji Medical University = Tong ji yi ke da xue xue bao · 2000

    Ex vivo tissue · 6 results

  42. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT.

    Baldanzi G · The Journal of cell biology · 2002

    In vitro (cells) · 7 results

  43. Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes.

    Gauna C · The Journal of clinical endocrinology and metabolism · 2005

    In vitro (cells) · pig · 1 result

  44. Ghrelin regulates proliferation and differentiation of osteoblastic cells.

    Maccarinelli G · The Journal of endocrinology · 2005

    In vitro (cells) · rat · 3 results

  45. The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells.

    Ghè C · Endocrinology · 2002

    In vitro (cells) · 7 results

  46. Natural (ghrelin) and synthetic (hexarelin) GH secretagogues stimulate H9c2 cardiomyocyte cell proliferation.

    Pettersson I · The Journal of endocrinology · 2002

    In vitro (cells) · 6 results

  47. Desacyl-ghrelin and synthetic GH-secretagogues modulate the production of inflammatory cytokines in mouse microglia cells stimulated by beta-amyloid fibrils.

    Bulgarelli I · Journal of neuroscience research · 2009

    In vitro (cells) · mouse · 2 results

  48. Proliferative and protective effects of growth hormone secretagogues on adult rat hippocampal progenitor cells.

    Johansson I · Endocrinology · 2008

    In vitro (cells) · rat · 6 results

  49. Hexarelin protects rat cardiomyocytes from angiotensin II-induced apoptosis in vitro.

    Pang JJ · American journal of physiology. Heart and circulatory physiology · 2004

    In vitro (cells) · rat · 4 results

  50. Leptin regulates GH gene expression and secretion and nitric oxide production in pig pituitary cells.

    Baratta M · Endocrinology · 2002

    In vitro (cells) · pig · 2 results

How PepBank reports evidence